# Transdermal Insulin Response In Healthy Volunteers

> **NCT04857320** · EARLY_PHASE1 · COMPLETED · sponsor: **Transdermal Delivery Solutions Corp** · enrollment: 7 (actual)

## Conditions studied

- Pharmacodynamic Response to Small Doses of Insulin

## Interventions

- **COMBINATION_PRODUCT:** Human insulin

## Key facts

- **NCT ID:** NCT04857320
- **Lead sponsor:** Transdermal Delivery Solutions Corp
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-12
- **Primary completion:** 2021-11-15
- **Final completion:** 2021-11-15
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04857320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04857320, "Transdermal Insulin Response In Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04857320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*